Rotex

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with muscles and joints in patients experiencing conditions such as arthritis, simple backache, strains, sprains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 18 years of age, the recommended dosage involves applying the product generously to the affected area. The application should be followed by a gentle massage into the painful area until the product is thoroughly absorbed into the skin. This process may be repeated as necessary, but should not exceed 3 to 4 applications per day. It is important to wash hands with soap and water immediately after use to prevent accidental contact with sensitive areas.

For children 18 years or younger, it is advised to consult a physician before use.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222.

Additionally, discontinue use and consult a healthcare professional if the following conditions occur: the condition worsens, symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Use should also be stopped if redness or irritation develops.

Warnings and Precautions

FOR EXTERNAL USE ONLY. This product should be utilized strictly as directed. It is imperative to avoid bandaging the treated area tightly and to refrain from using it in conjunction with a heating pad. Contact with the eyes or mucous membranes must be avoided to prevent irritation. The product should not be applied to wounds, damaged, broken, or irritated skin.

Upon application, a transient burning sensation may occur; however, this typically resolves within several days. Should a severe burning sensation arise, the use of the product must be discontinued immediately, and a healthcare professional should be contacted.

It is crucial to avoid exposing the treated area to heat or direct sunlight to prevent adverse effects. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222.

Patients should be advised to discontinue use and consult a physician if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve only to recur within a few days. Additionally, if redness or irritation develops, medical advice should be sought promptly.

Side Effects

Patients using this product may experience a range of adverse reactions, which can be categorized by seriousness and frequency.

A transient burning sensation is commonly reported upon application; this sensation typically resolves within several days. However, if patients experience a severe burning sensation, they are advised to discontinue use immediately and consult a healthcare professional.

It is important to note that the product is intended for external use only. Patients should avoid applying it to wounds, damaged, broken, or irritated skin, and should not bandage the area tightly. Additionally, the use of heating pads in conjunction with this product is contraindicated. Patients should also take care to avoid contact with the eyes or mucous membranes and refrain from exposing the treated area to heat or direct sunlight.

Patients are instructed to stop use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. The presence of redness or the development of irritation should also prompt consultation with a healthcare provider.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Rotex (rotex pain relieving cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 18 years of age or younger should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers should consider individual circumstances and the specific needs of the patient when making recommendations.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, there is currently no specific information available regarding the effects or management of such an occurrence. Healthcare professionals are advised to monitor the patient closely and provide supportive care as needed. It is essential to assess the patient's clinical status and implement standard emergency protocols for overdose situations.

In the absence of detailed guidance, practitioners should consider consulting local poison control centers or relevant medical authorities for further assistance in managing potential overdosage cases.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology. As such, a comprehensive assessment of these aspects cannot be made at this time.

Postmarketing Experience

A transient burning sensation has been reported upon application of the product; this sensation typically resolves within several days. In cases where a severe burning sensation occurs, it is advised to discontinue use immediately and consult a healthcare professional.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222.

Providers should instruct patients to discontinue use and consult a doctor if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, patients should be informed to seek medical advice if they experience any redness or irritation while using the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20°-25°C (68°-77°F) to maintain its integrity and efficacy. Care should be taken to avoid exposure to direct sunlight, as this may compromise the quality of the product. Proper storage conditions are crucial for ensuring optimal performance and safety.

Additional Clinical Information

The product is administered topically, with instructions for adults and children over 18 years to apply generously to the affected area and massage until fully absorbed. This application may be repeated as necessary, not exceeding 3-4 times daily, and hands should be washed with soap and water immediately after use. For children under 18 years, consultation with a doctor is advised prior to use.

Clinicians should counsel patients to seek advice from a healthcare professional if they are pregnant or breastfeeding before using the product. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Rotex, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)